Publications

Sort by: Date | Author | Title

Box, J. R., Camilo-Contreras, A., Dragoni, F., Yue, F. Y., Matveev, V., Foley, J., Zhang, J., Mok, Y. W., DeSousa, M., Lai, J., Mulcare, Z., Bakewell, Z., Poulin, S., Chano, F., Fortin, C., Tremblay, C., Blankson, J. N., Krishnan, S., Weld, E. D. ... Simonetti, F. R. (2026). 5′ leader defects drive persistent HIV-1 viremia on long-term ART. Nature Communications, 17(1), Article 4725. https://doi.org/10.1038/s41467-026-73475-5
Fournier, M., Vanderkerken, M., Dorgham, K., Bastard, P., Ahouzi, O., Duquerroy, S., Nguyen, N. K., Broutin, M., Charlet, M., Vandenberghe, A., Van Endert, P., Bizien, L., Da Mata-Jardin, O., Ferriño-Iriarte, A., Haouz, A., Belmondo, T., Hüe, S., Borghesi, A., Rodríguez-Gallego, C. ... COVID Human Genetic Effort (2026). Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections. Cell, 189(11), 3236-3253.e23. https://doi.org/10.1016/j.cell.2026.04.013
Lassen, M. C. H., Christensen, S. H., Johansen, N. D., Aliabadi, N., Skaarup, K. G., Modin, D., Claggett, B. L., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Lindholm, M. G., Køber, L., Solomon, S. D., Stæhr Jensen, J. U., Martel, C. J. M., Schwarz, C., Gonzalez, E., Skovdal, M. ... Biering-Sørensen, T. (2026). A pragmatic individually randomized trial to evaluate bivalent RSV prefusion F protein–based vaccine effectiveness for preventing RSV hospitalizations in adults aged 60 years or above (DAN-RSV): Rationale and trial design. American Heart Journal, 291, 14-25. https://doi.org/10.1016/j.ahj.2025.07.068
Johansen, N. D., Modin, D., Loiacono, M. M., Harris, R. C., Dufournet, M., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Claggett, B. L., Skaarup, K. G., Davidovski, F. S., Solomon, S. D., Landray, M. J., Gislason, G. H., Køber, L., Sivapalan, P., Martel, C. J. M., Jensen, J. U. S. & Biering-Sørensen, T. (2026). A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial. American Heart Journal, 291, 186-198. https://doi.org/10.1016/j.ahj.2025.07.069
Lassen, M. C. H., Christensen, S. H., Johansen, N. D., Yafasov, M., Pareek, M., Rudolph, A. E., Tenreiro-Sánchez, C. R., Skaarup, K. G., Modin, D., Claggett, B. L., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Lindholm, M. G., Køber, L., Solomon, S. D., Jensen, J. U. S., Martel, C. J. M. ... Biering-Sørensen, T. (2026). A pragmatic randomized trial to evaluate the vaccine effectiveness of bivalent RSV prefusion F vaccine for preventing RSV hospitalizations in adults (DAN-RSV): Trial design update. American Heart Journal, 300, Article 107497. https://doi.org/10.1016/j.ahj.2026.107497
Jensen, J. A., Mørk, N., Tolstrup, M., Søgaard, O., Dalhuisen, T., Rodriguez, A., Hoh, R., Peluso, M. J., Deeks, S. G., Casanova, J.-L. & Mogensen, T. H. (2026). Autoantibodies neutralizing type 1 interferons in two cohorts of people with HIV. Journal of human immunity, 2(2), Article e20250179. https://doi.org/10.70962/jhi.20250179
Gervais, A., Marchal, A., Boucherit, S., Abi Haidar, A., Bizien, L., Yalcinkaya, A., Sandström, E., Kong, X. F., Jacquemin, E., Bernard, O., Debray, D., Lacaille, F., Ichai, P., Arikan, C., Javouhey, E., Roquelaure, B., Gottrand, F., Trespidi, F., Codullo, V. ... Jouanguy, E. (2026). Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis. The Journal of Experimental Medicine, 223(3), Article e20251760. https://doi.org/10.1084/jem.20251760